1132832-75-7Relevant articles and documents
Preparation method of intermediate
-
, (2020/06/29)
The invention discloses a preparation method for a Canagliflozin intermediate. The preparation method comprises the steps that substituted bromobenzene as a starting material is reacted with bisdiboron to prepare a boride, and then the Canagliflozin intermediate is prepared through a Suzuki coupling reaction, a Friedel-Crafts acylation reaction and a reduction reaction. The preparation method hasthe advantages that the intermediate product CZ-2 is prepared through the Suzuki coupling reaction, the conditions are mild and easy to operate and control, and the product yield and the product purity are high; aryl methyl is introduced through the Friedel-Crafts acylation reaction, a main chain is built, by means of the route, the yield is high, technological conditions are easy to control, andthe preparation method is suitable for large-scale industrial production.
Preparation method of 2-(4-fluorophenyl)-5-[(5-bromo-2-methylphenyl)methyl]thiophene
-
Paragraph 0033; 0037; 0038, (2020/06/17)
The invention relates to the technical field of medicine synthesis, and particularly discloses a preparation method of 2-(4-fluorophenyl)-5-[(5-bromo-2-methylphenyl)methyl]thiophene. The preparation method comprises the following steps: by taking a nitrogen-doped carbon material loaded with transition metal as a catalyst, introducing hydrogen, and performing hydrogenation reduction on 2-methyl-5-bromophenyl-2-(4-fluorophenyl)thiophene ketone at 50-180 DEG C, thereby obtaining 2-(4-fluorophenyl)-5-[(5-bromo-2-methylphenyl)methyl]thiophene. The preparation method provided by the invention has the characteristics of the high product yield, high purity, the low cost, no toxicity and no pollution, and overcomes the defects in the traditional preparation process of 2-(4-fluorophenyl)-5-[(5-bromo-2-methylphenyl)methyl]thiophene.
Synthesis method of canagliflozin intermediate
-
, (2018/03/26)
The invention relates to a synthesis method of a canagliflozin intermediate. Concretely, succinyl oxide and fluorobenzene are used as starting raw materials to be prepared into the canagliflozin crucial intermediate of 2-(4-fluorophenyl)-5-[(5-halogen-2-methyl phenyl)methyl]thiophene through the steps of Friedel-Crafts acylation ring opening, thiophene ring preparation, Friedel-Crafts acylation coupling, reduction and the like. The cheap succinyl oxide is used for preparing the thiophene ring, so that the Suzuki coupling reaction and Grignard reaction are avoided; the use of heavy metal reagents of palladium and the like is avoided; the production process is simplified; the product yield and the quality are improved; the environment pollution is reduced; the production cost is reduced.
A new SGLT2 inhibitor pharmaceutical preparation method
-
Paragraph 0037; 0048; 0058-0059, (2018/03/24)
The invention discloses a preparation method for novel SGLT2 inhibitor medicine. The preparation method includes the steps that D-gluconolactone serves as an initial raw material and reacts with an acylation reagent under the action of a base to obtain a glucolactone intermediate with hydroxyl protection; 5-bromine-2-methyl benzoic acid is prepared into an acid chloride through an acylation reagent, and the acid chloride and 2-(4-fluoro-phenyl) thiophene perform friedel-Crafts acylation reaction under the action of Lewis acid; 2-(5-bromine-2-methyl-benzoyl)-5-(4-fluoro-phenyl) thiophene and the glucolactone intermediate perform electrophilic substitution reaction under the action of super-strong bases, and then etherification reaction is performed to obtain methyl etherate; the methyl etherate restores carbonyl into methylene under the action of a reducing agent, and an methoxy group is removed to form an S-configuration aromatic gluconolactone intermediate; the aromatic gluconolactone intermediate is hydrolyzed under the action of a base to obtain a canagliflozin product. The synthesis process route is short and simple, the quality of the intermediate is easy to control, the reaction yield is high, the production cost is low, and the preparation method is suitable for industrialized production.
Deuterium-modified carbon glycoside derivate
-
Paragraph 0089; 0090; 0091; 0098; 0099; 0100, (2016/12/26)
The invention belongs to the field of medinal chemistry and relates to a deuterium-modified carbon glycoside derivate, in particular to a compound shown in the formula I. The invention further relates to a preparation method of the deuterium-modified carbon glycoside derivate, a medicine composition comprising the deuterium-modified carbon glycoside derivate and application of the deuterium-modified carbon glycoside derivate or the medicine composition thereof for preparing medicine for treating diabetes.
PROCESS FOR THE PURIFICATION OF CANAGLIFLOZIN
-
Page/Page column 6; 7, (2016/03/12)
The present invention provides a process for the preparation of (1S)-2,3,4,6-tetra- O-acetyl-1,5-anhydro-1-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D- glucitol of Formula III. The invention also provides a process for the purification of canagliflozin using (1S)-2,3,4,6-tetra-O-acetyl-1,5-anhydro-1-[3-[[5-(4-fluorophenyl)-2-5 thienyl]methyl]-4-methylphenyl]-D-glucitol of Formula III.
Synthesis of 2-arylmethyl-5-aryl-thiophene
-
, (2015/11/09)
The present invention provides a new synthetic process for the production of 2-arylmethyl-5-aryl-thiophene, an intermediate in the synthesis of C-aryl glycosides.
FAMILY OF ARYL, HETEROARYL, O-ARYL AND O-HETEROARYL CARBASUGARS
-
, (2012/12/13)
The present invention relates to a compound of the following formula (I): as well as its process of preparation, pharmaceutical and cosmetics composition comprising it and use thereof, notably as an inhibitor of the sodium-dependent glucose co-transporter, such as SGLTl, SGLT2 and SGLT3, in particular in the treatment or prevention of diabetes, and more particularly type-II diabetes, diabetes-related complications, such as arthritis of the lower extremities, cardiac infarction, renal insufficiency, neuropathy or blindness, hyperglycemia, hyperinsulinemia, obesity, hypertriglyceridemia, X syndrome and arteriosclerosis, as well as for its use as an anticancer, anti-infective, anti-viral, anti-thrombotic or anti- inflammatory drug, or for lightening, bleaching, depigmenting the skin, removing blemishes from the skin, particularly age spots and freckles, or preventing pigmentation of the skin.
Discovery of canagliflozin, a novel C-glucoside with thiophene ring, as sodium-dependent glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes mellitus (1)
Nomura, Sumihiro,Sakamaki, Shigeki,Hongu, Mitsuya,Kawanishi, Eiji,Koga, Yuichi,Sakamoto, Toshiaki,Yamamoto, Yasuo,Ueta, Kiichiro,Kimata, Hirotaka,Nakayama, Keiko,Tsuda-Tsukimoto, Minoru
experimental part, p. 6355 - 6360 (2010/11/03)
We discovered that C-glucosides 4 bearing a heteroaromatic ring formed metabolically more stable inhibitors for sodium-dependent glucose cotransporter 2 (SGLT2) than the O-glucoside, 2 (T-1095). A novel thiophene derivative 4b-3 (canagliflozin) was a highly potent and selective SGLT2 inhibitor and showed pronounced anti-hyperglycemic effects in high-fat diet fed KK (HF-KK) mice.
PROCESS FOR THE PREPARATION OF COMPOUNDS USEFUL AS INHIBITORS OF SGLT
-
Page/Page column 76, (2009/04/25)
The present invention is directed to a novel process for the preparation of compounds having inhibitory activity against sodium-dependent glucose transporter (SGLT) being present in the intestine or kidney.